Differentiating celiac disease from other diseases: Difference between revisions

Jump to navigation Jump to search
Skazmi (talk | contribs)
No edit summary
Mmir (talk | contribs)
Line 135: Line 135:
|
|
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
* Blood seen on [[rectal exam]]
* [[Tachycardia]]
*[[Fever]]
*[[Tachycardia]]
*[[Hypotension]]
*[[Hypotension]]
|
|
Line 147: Line 145:
* Elevated [[C-reactive protein|CRP]]
* Elevated [[C-reactive protein|CRP]]
|
|
* Topical mucosamine and [[corticosteroids]] are preferred
* Blood seen on [[rectal exam]]
* [[Mesalamine]] and [[sulfasalazine]] are used for remission
* [[Fever]]
|Abnormal immune response to self [[antigens]]
|Abnormal immune response to self [[antigens]]
|
|
Line 156: Line 154:
| +
| +
| -
| -
|
|Any age
|
|<nowiki>+</nowiki>
|
|<nowiki>-</nowiki>
|
|<nowiki>+/-</nowiki>
|
|
* Lump in the neck
* Lump in the neck
Line 166: Line 164:
* Increased [[Deep tendon reflex|DTR]]
* Increased [[Deep tendon reflex|DTR]]
|
|
*  
* Elevated T4
* Elevated T3
* Decreased level of TSH
|
|
*  
* Stare
* Lid lag
* Sweating
* Hyperpigmentation
|
|
* Graves' disease
* Hashimoto thyrotoxicosis
* Toxic adenoma
|
|
* [[TSH]] with [[T3]] and [[T4]]
* [[TSH]] with [[T3]] and [[T4]]
Line 176: Line 182:
| +
| +
| -
| -
|
|between 30 and 50
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
|<nowiki>+/-</nowiki>
|
|<nowiki>+/-</nowiki>
|
|
* [[Tachycardia]]  
* [[Tachycardia]]  
Line 188: Line 194:
* [[Abdominal tenderness]] in the right upper abdominal quadrant
* [[Abdominal tenderness]] in the right upper abdominal quadrant
|
|
*
*hypokalemia
*Hypochlorhydria or achlorhydria
*low osmotic gap (<50 mOsm/kg)
|
|
* [[Dehydration]]  
* [[Dehydration]]  
Line 194: Line 202:
* [[Nausea]], [[vomiting]]
* [[Nausea]], [[vomiting]]
* [[Flushing]]
* [[Flushing]]
|
|Primary secretory tumor
|
|
* Elevated [[VIP]] levels
* Elevated [[VIP]] levels
Line 202: Line 210:
| +
| +
| -
| -
|
|between 30 and 50
|
|<nowiki>-</nowiki>
|
|<nowiki>-</nowiki>
|
|<nowiki>+</nowiki>
|
|
* [[Abdominal tenderness]]
* [[Abdominal tenderness]]
* Hard stool in the rectal vault
* Hard stool in the rectal vault
|<nowiki>-</nowiki>
|
|
|
* [[Bloating|Bloating]]
* High [[dietary fiber]]
* [[Flatulence]]
* [[Osmotic]] [[laxatives]] such as [[polyethylene glycol]], [[sorbitol]], and [[lactulose]]
|Postinfectious
* [[Antispasmodic]] drugs (e.g. [[Anticholinergic|anticholinergics]] such as [[hyoscyamine]] or [[dicyclomine]])
 
|
Inflammatory
|
|
* [[Diagnosis|Clinical diagnosis]]
* [[Diagnosis|Clinical diagnosis]]
Line 223: Line 232:
| -
| -
| +
| +
|
|Adolescents and increase risk with age
|
|<nowiki>+</nowiki>
|
|<nowiki>-</nowiki>
|
|<nowiki>+/-</nowiki>
|
|
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
* [[Abdominal]] [[tenderness ]]when palpated in severe [[disease]]
Line 234: Line 243:
* [[Nausea and vomiting]]
* [[Nausea and vomiting]]
|
|
* [[Bloating|Bloating,]]
* [[Hydrogen Breath Test|Lactose breath hydrogen test]]
|
* [[Bloating|Bloating]]
* [[Flatulence]]
* [[Flatulence]]
* Symptoms begin mainly after ingestion of [[lactose]]
* Symptoms begin mainly after ingestion of [[lactose]]
|
|
|
|lactase activity assay
|[[Hydrogen Breath Test|Lactose breath hydrogen test]]
|-
|-
|[[Whipple's disease|Whipple disease]]
|[[Whipple's disease|Whipple disease]]
| -
| +/-
| +
| +
|
|50th
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|<nowiki>-</nowiki>
|<nowiki>-</nowiki>
|<nowiki>+</nowiki>
|<nowiki>+</nowiki>
|
|
*  
* arthralgias of the large joints
* [[Hematochezia]]
|
|
* [[Leukocytopenia]]
* [[Leukocytopenia]]
Line 256: Line 267:
* [[Skin hyperpigmentation]]
* [[Skin hyperpigmentation]]
* [[Arthralgias]]
* [[Arthralgias]]
|
|''Tropheryma whipplei'' 
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]])
|Upper [[endoscopy]] with [[biopsies]] of the [[small intestine]] for ''[[Tropheryma whipplei|T. whipplei]]'' testing ([[histology]] with [[Periodic acid-Schiff stain|PAS staining]], [[polymerase chain reaction]] [[[PCR]]] testing, and [[immunohistochemistry]])
|-
|-
Line 276: Line 287:
* triggered by cow's milk protein
* triggered by cow's milk protein
* profuse, repetitive vomiting
* profuse, repetitive vomiting
|
|Autoimmune/allergic response to food antigens
|[[oral]] food challenge (OFC)
|[[oral]] food challenge (OFC)
|-
|-
Line 296: Line 307:
* one-half of patients have other [[allergic diseases]]
* one-half of patients have other [[allergic diseases]]
* associated with an identifiable [[dietary]] [[antigen]]
* associated with an identifiable [[dietary]] [[antigen]]
|
|Autoimmune/allergic response to food antigens
|[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
|[[eosinophilic]] infiltration of the [[gastrointestinal tract]] on [[biopsy]]
|-
|-
Line 321: Line 332:
** [[Arthritis]]
** [[Arthritis]]
** [[Uveitis]]
** [[Uveitis]]
|
|mucosal immune responses to luminal factors in a genetically predisposed individual
|
|
* A [[colonoscopy]] with [[mucosal]] [[biopsy]] with mononuclear infiltrates:
* A [[colonoscopy]] with [[mucosal]] [[biopsy]] with mononuclear infiltrates:
Line 341: Line 352:
|
|
* History of [[polyhydramnios]]
* History of [[polyhydramnios]]
* [[Mutations]] in the ''SLC26A3'' gene
** Encodes for an [[epithelial]] [[anion]] exchanger 
|
|
[[Mutations]] in the ''SLC26A3'' gene
* Encodes for an [[epithelial]] [[anion]] exchanger 
|
|
* Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]]
* Excessive [[Fecal|feca]]<nowiki/>l secretion of [[chloride]]
Line 363: Line 375:
|
|
* May be associated with [[Choanal atresia|choanal]] or [[anal atresia]]
* May be associated with [[Choanal atresia|choanal]] or [[anal atresia]]
|
|mutations in the ''SPINT2'' gene
|
|Clinical
|-
|-
|[[Glucose|Glucose-]][[galactose]] [[malabsorption]]
|[[Glucose|Glucose-]][[galactose]] [[malabsorption]]
Line 374: Line 386:
| +
| +
|[[Abdominal tenderness]]
|[[Abdominal tenderness]]
|
|S/E:
* Acidic
|
|
* severe life-threatening [[diarrhea]]
* severe life-threatening [[diarrhea]]
Line 380: Line 393:
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
* Symptomatic as long as the diet includes [[lactose]] or its [[hydrolysis]] products, [[glucose]] and [[galactose]]
|
|
* Mutations in solute carrier family 5, member 1 gene (''SLC5A1'', also known as ''SGLT1'')
** Lead to deficiency in the intestinal sodium/glucose transporter
|
|
* positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]]
* positive [[glucose]] breath [[hydrogen]] test + normal intestinal [[biopsy]]
Line 400: Line 415:


Low [[vitamin E]] levels
Low [[vitamin E]] levels
|[[Clumsiness]]
|
vision impairment
* [[Clumsiness]]
 
* vision impairment
[[Ataxia]]
* [[Ataxia]]
|
|
* [[autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
* [[autosomal recessive]] disorder caused by mutations encoding the [[microsomal]] [[triglyceride]] transfer protein (MTP)
Line 417: Line 432:
| -
| -
|
|
|Disease [[hetergenicity]] lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
* Low Vitamin A-K-E-D
* Anemia
|
* Disease hetergenicity lead to varying presentation from chronic [[diarrhea]] without significant fat [[Malabsorption|malabsorptio]]<nowiki/>n to severe [[watery diarrhea]] and steatorrhea with [[malnutrition]]
|
|
* [[genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
* [[genetic defects]] in ''SLC10A2'' (solute carrier family 10 member 2 gene)
Line 447: Line 465:
| +/-
| +/-
| +
| +
|Mild to moderate upper [[abdominal tenderness]]
|
|Positive [[secretin]] stimulation test
* Mild to moderate upper [[abdominal tenderness]]
Elevated serum [[chromogranin A]]
|
|[[heartburn]]
* Positive [[secretin]] stimulation test
* Elevated serum [[chromogranin A]]
|
* [[heartburn]]
|[[Gastrin]] producing tumor mainly in [[duodenum]]
|[[Gastrin]] producing tumor mainly in [[duodenum]]
|elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL
|elevated basal or stimulated serum [[gastrin]] more than 1000 pg/mL

Revision as of 11:13, 13 September 2017

Celiac disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Celiac disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Life Style Modifications
Pharmacotherapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Differentiating celiac disease from other diseases On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Differentiating celiac disease from other diseases

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

National Guidelines Clearinghouse

NICE Guidance

FDA on Differentiating celiac disease from other diseases

CDC on Differentiating celiac disease from other diseases

Differentiating celiac disease from other diseases in the news

Blogs onDifferentiating celiac disease from other diseases

Directions to Hospitals Treating Celiac disease

Risk calculators and risk factors for Differentiating celiac disease from other diseases

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Differentiating Celiac Disease from Other Diseases

Celiac disease must be differentiated from other diseases presenting as chronic diarrhea. The table below summarizes the findings that differentiate causes of chronic diarrhea[1][2][3][4][5][6][7]

Cause Diarrhea Age of onset History Physical exam Lab findings Additional finding Cause Gold standard dignosis
Watery Fatty Weight loss FTT Abdominal pain
Celiac disease +/- +/- Childhood

Adult

+ + +
Lactose intolerance + - Adult - - +
  • Stool osmotic gap of >125 mOsm/kg 
  • Stool pH <6 
Cystic fibrosis - + Infancy and childhood + + + Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) protein
Laxative overuse + - After childhood +/- - +/- - Laxative drug abuse
Crohns disease + - Young adults

(20th)

+ + Abnormal immune response to self antigens
Hyperthyroidism + - Any age + - +/-
  • Elevated T4
  • Elevated T3
  • Decreased level of TSH
  • Stare
  • Lid lag
  • Sweating
  • Hyperpigmentation
  • Graves' disease
  • Hashimoto thyrotoxicosis
  • Toxic adenoma
VIPoma + - between 30 and 50 + +/- +/-
  • hypokalemia
  • Hypochlorhydria or achlorhydria
  • low osmotic gap (<50 mOsm/kg)
Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Irritable bowel syndrome + - between 30 and 50 - - + - Postinfectious

Inflammatory

lactose intolerance - + Adolescents and increase risk with age + - +/- lactase activity assay
Whipple disease +/- + 50th + - + Tropheryma whipplei  Upper endoscopy with biopsies of the small intestine for T. whipplei testing (histology with PAS staining, polymerase chain reaction [[[PCR]]] testing, and immunohistochemistry)
Allergic enteropathy/Food protein-induced enterocolitis syndrome (FPIES) + - Infancy +/- +/- + S/E:
  • triggered by cow's milk protein
  • profuse, repetitive vomiting
Autoimmune/allergic response to food antigens oral food challenge (OFC)
Eosinophilic gastroenteritis  + - 3rd decade +/- +/- + Autoimmune/allergic response to food antigens eosinophilic infiltration of the gastrointestinal tract on biopsy
Microscopic colitis + - 6th decde + - + mucosal immune responses to luminal factors in a genetically predisposed individual
Congenital chloride diarrhea + - Neonate + + - -

Mutations in the SLC26A3 gene

Congenital sodium diarrhea + - Neonate + + - - S/E:

Serum:

mutations in the SPINT2 gene Clinical
Glucose-galactose malabsorption + - Infancy + +/- + Abdominal tenderness S/E:
  • Acidic
  • Mutations in solute carrier family 5, member 1 gene (SLC5A1, also known as SGLT1)
    • Lead to deficiency in the intestinal sodium/glucose transporter
Abetalipoproteinemia - + Infancy + + + Abdominal distention

Impaired visual acuity and visual field defects

Dysarthria 

Low triglyceride

Low total cholesterol levels 

Acanthocytes 

Low vitamin E levels

Clinical findings and low triglyceride and cholesterol level
Primary bile acid malabsorption + +/- Childhood Adolescents + + +/- -
  • Low Vitamin A-K-E-D
  • Anemia
Cause Diarrhea Age of onset History Physical exam Lab findings Additional finding Cause Gold standard dignosis
Watery Fatty Weight loss FTT Abdominal pain
Gastrinoma (Zollinger-Ellison syndrome) + - between the ages of 20 and 50 + +/- + Gastrin producing tumor mainly in duodenum elevated basal or stimulated serum gastrin more than 1000 pg/mL

(solute-linked carrier famly 26 member A3)

oral food challenge (OFC):

References

  1. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR; et al. (2005). "Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology". Can J Gastroenterol. 19 Suppl A: 5A–36A. PMID 16151544.
  2. Sauter GH, Moussavian AC, Meyer G, Steitz HO, Parhofer KG, Jüngst D (2002). "Bowel habits and bile acid malabsorption in the months after cholecystectomy". Am J Gastroenterol. 97 (7): 1732–5. doi:10.1111/j.1572-0241.2002.05779.x. PMID 12135027.
  3. Maiuri L, Raia V, Potter J, Swallow D, Ho MW, Fiocca R; et al. (1991). "Mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia". Gastroenterology. 100 (2): 359–69. PMID 1702075.
  4. RUBIN CE, BRANDBORG LL, PHELPS PC, TAYLOR HC (1960). "Studies of celiac disease. I. The apparent identical and specific nature of the duodenal and proximal jejunal lesion in celiac disease and idiopathic sprue". Gastroenterology. 38: 28–49. PMID 14439871.
  5. Hertzler SR, Savaiano DA (1996). "Colonic adaptation to daily lactose feeding in lactose maldigesters reduces lactose intolerance". Am J Clin Nutr. 64 (2): 232–6. PMID 8694025.
  6. Briet F, Pochart P, Marteau P, Flourie B, Arrigoni E, Rambaud JC (1997). "Improved clinical tolerance to chronic lactose ingestion in subjects with lactose intolerance: a placebo effect?". Gut. 41 (5): 632–5. PMC 1891556. PMID 9414969.
  7. BLACK-SCHAFFER B (1949). "The tinctoral demonstration of a glycoprotein in Whipple's disease". Proc Soc Exp Biol Med. 72 (1): 225–7. PMID 15391722.

Template:WH Template:WS